癌前子宫内膜病变子宫切除术中淋巴结评估的临床价值有限
本研究纳入2009至2019年因癌前子宫内膜病变行子宫切除术的141例患者,评估最终病理符合Mayo淋巴结清扫标准的比例。36%最终诊断为癌,仅5%符合Mayo标准,淋巴结转移率为0%,中位随访24.3个月无复发,提示普遍淋巴结评估价值有限。
要点
- 癌前子宫内膜病变患者最终病理仅5%符合Mayo淋巴结清扫标准。
- 最终诊断为癌的患者中淋巴结转移率为0%,随访无复发。
- 对癌前病变患者普遍进行淋巴结评估临床价值有限。
核心结论
- 非典型增生或子宫内膜上皮内瘤变患者最终病理多为低危疾病,普遍淋巴结评估价值有限。
研究设计与样本
- 回顾性纳入2009至2019年因癌前子宫内膜病变(非典型增生或子宫内膜上皮内瘤变)行子宫切除术的141例患者。
主要发现
- 141例中51例(36%)最终诊断为癌,其中96%为IA期1级子宫内膜样癌。
- 7例(5%)最终病理符合Mayo标准(1例3级、7例肿瘤>2 cm、1例肌层浸润>50%)。
- 7例符合Mayo标准者中3例评估淋巴结,均无转移;6例行冰冻切片,2例(33%)术中符合Mayo标准。
- 51例癌患者中仅10例经冰冻切片诊断,仅2例术中符合Mayo标准。
- 年龄>55岁可预测最终病理符合Mayo标准(p=0.007);中位随访24.3个月无复发。
关键数值与推荐
- Mayo标准:1例3级、7例肿瘤>2 cm、1例肌层浸润>50%。
- 年龄>55岁预测最终病理符合Mayo标准(p=0.007)。
临床怎么用
- 对癌前子宫内膜病变患者,子宫切除术中普遍淋巴结评估的临床价值有限,可考虑选择性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to determine the proportion of patients with a pre-invasive endometrial lesion who meet Mayo criteria for lymph node dissection on final pathology to determine if the use of sentinel lymph node biopsy in patients with pre-invasive lesions would be warranted. METHODS: All women who underwent hysterectomy for a pre-invasive endometrial lesion (atypical hyperplasia or endometrial intra-epithelial neoplasia) between 2009 and 2019 were included for analysis. Relevant statistical tests were utilized to test the associations between patient, operative, and pathologic characteristics. RESULTS: 141 patients met inclusion criteria. 51 patients (36%) had a final diagnosis of cancer, the majority (96%) of which were Stage IA grade 1 endometrioid carcinomas. Seven patients (5%) met Mayo criteria on final pathology (one grade 3, seven size >2 cm, one >50% myoinvasive). Three of these seven patients had lymph nodes assessed of which 0% had metastases. Six of these patients had frozen section performed, and 2 met (33%) Mayo criteria intraoperatively. Of the seven patients in the overall cohort that had lymph node sampling, six had a final diagnosis of cancer and none had positive lymph nodes. Of the 51 patients with cancer, only 10 had cancer diagnosed using frozen section, and only two met intra-operative Mayo criteria. Age > 55 was predictive of meeting Mayo criteria on final pathology (p = 0.007). No patients experienced a cancer recurrence across a median follow up of 24.3 months. CONCLUSIONS: Atypical hyperplasia and endometrial intra-epithelial neoplasia portend low risk disease and universal nodal assessment is of limited value.
引用
- Sullivan MW, Philp L, Kanbergs AN, et al. Lymph node assessment at the time of hysterectomy has limited clinical utility for patients with pre-cancerous endometrial lesions. Gynecol Oncol. 2021. PMID: 34247769. doi:10.1016/j.ygyno.2021.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。